Medications

FDA approves once-a-day inhaler from Glaxo

The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.

Medications

US panel backs inhaler drug for lung disease

A panel of U.S. respiratory experts voted Wednesday in favor of approving an experimental inhaler drug from GlaxoSmithKline and Theravance for treating chronic lung disease.

Diseases, Conditions, Syndromes

Rubella in pregnancy rare in US, but can be devastating for baby

(HealthDay)—Although rare in the United States, three babies with birth defects caused by rubella (or "German measles") were reported in 2012 and doctors need to be on the lookout for such cases, a new government report ...

page 7 from 9